Fig. 11From: Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacyCorrelation between PTPN3 expression and drug sensitivity. The PTPN3 was linked to the sensitivity of A Okadaic acid, B Nelarabine, C Lapatinib, D Pipamperone, E Gefitinib, F 8-Chloro-adenosine, G Tyrothricin, H Afatinib, I Olaparib, J AZD-9291, K Ethinyl estradiol, L Amonafide, M Paclitaxel, N Vinblastine, O Estramustine, P IbrutinibBack to article page